Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class university research into business, is pleased to announce that it has appointed Seymour Pierce Ltd as its Nominated Adviser and Broker with immediate effect.
About Fusion IP
Fusion IP plc, previously called Biofusion plc, was established in 2002 to commercialise university-generated IP. Fusion IP has signed long term agreements with two of the UK’s leading research intensive universities, the University of Sheffield and Cardiff University, giving a combined R&D spend attributable to Fusion IP of approximately £185 million a year.
Fusion IP’s first agreement was a ten-year exclusive arrangement with the University of Sheffield for the commercialisation of IP owned by the University initially in the area of medical life sciences. This agreement was expanded in July 2008 to include the commercialisation of all non-life science research-generated IP, giving Fusion IP access to all of the University’s world class research in areas such as energy, engineering and electronics. Fusion IP has shareholdings in a portfolio of Sheffield University spin-out companies including Asterion, Diurnal, Magnomatics and Phase Focus. The University of Sheffield will be spending approximately £1 billion of research funding over the lifetime of the Sheffield Agreement.
In January 2007, Fusion IP completed a long-term exclusive agreement with Cardiff University, to commercialise 100% of all Cardiff University’s research-generated IP. Fusion IP has shareholdings in a portfolio of Cardiff University spin-out companies including Mesuro and Q-Chip. Cardiff University will be spending more than £1.0bn of research funding over the lifetime over the life of the Cardiff Agreement.
Fusion IP also has a Memorandum of Understanding with Finance Wales, the provider of commercial funding to Wales-based SMEs, which outlines a strategy of co-investment in opportunities arising from the Cardiff University agreement.
